TuHURA Biosciences HURA
NASDAQ HURA
$1.52 +0.01 (+0.66%)
At close: Nov 11, 2026 · 4:00 PM EST

TuHURA Biosciences (HURA) Short term Debt (2014 - 2026)

Updated

TuHURA Biosciences (HURA) posted Short term Debt of $503,000 for Q3 2021, up 6.3% from the prior quarter.

Analysis

TuHURA Biosciences (HURA) Short term Debt (2014 - 2026) Analysis & Trends

Since Q1 2015, TuHURA Biosciences has reported Short term Debt for 4 quarters.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 TuHURA Biosciences 96.16 Mn 82.54 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.60 Mn
Mar 31, 2021 503,000.00
Dec 31, 2020 473,000.00
Sep 30, 2020 441,000.00
Sep 30, 2014 279,000.00
API Access

TuHURA Biosciences Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=HURA&period=max&api_key=YOUR_API_KEY